{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:58:13Z","timestamp":1789243093377,"version":"build-2803163510"},"reference-count":149,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008250","name":"Northwestern University Feinberg School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008250","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ernest Bazley Foundation"},{"name":"OptiNose"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jaip.2020.01.031","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T02:42:04Z","timestamp":1580179324000},"page":"1522-1531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Current and Future Treatments of Rhinitis and Sinusitis"],"prefix":"10.1016","volume":"8","author":[{"given":"Gayatri B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Park","family":"Hae-Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju T.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.01.031_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/lary.25180","article-title":"Cost of adult chronic rhinosinusitis: a systematic review","volume":"125","author":"Smith","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2500\/ajra.2016.30.4297","article-title":"Chronic rhinosinusitis: epidemiology and burden of disease","volume":"30","author":"DeConde","year":"2016","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/WOX.0b013e3181865faf","article-title":"Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in Europe and the United States","volume":"1","author":"Canonica","year":"2008","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2020.01.031_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clinthera.2007.02.007","article-title":"Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis","volume":"29","author":"Long","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2020.01.031_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/all.13356","article-title":"Quality of life is significantly impaired in nonallergic rhinitis patients","volume":"73","author":"Segboer","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib6","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.anai.2010.10.014","article-title":"The economic impact of allergic rhinitis and current guidelines for treatment","volume":"106","author":"Meltzer","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1081-1206(10)60830-7","article-title":"Economic burden of rhinitis in managed care: a retrospective claims data analysis","volume":"101","author":"Dalal","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/resp.12838","article-title":"Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life","volume":"21","author":"Tay","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2020.01.031_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.01.031_bib10","doi-asserted-by":"crossref","first-page":"e0171047","DOI":"10.1371\/journal.pone.0171047","article-title":"Impact of chronic rhinosinusitis on severe asthma patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2020.01.031_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2500\/ajra.2011.25.3613","article-title":"Association between severity of asthma and degree of chronic rhinosinusitis","volume":"25","author":"Lin","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib12","article-title":"Chronic rhinitis is a high-risk comorbidity for 30-day hospital readmission of patients with asthma and chronic obstructive pulmonary disease","volume":"7","author":"Singh","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.01.031_bib14","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/all.12222","article-title":"Chronic rhinosinusitis in asthma is a negative predictor of quality of life: results from the Swedish GA(2)LEN survey","volume":"68","author":"Ek","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2500\/aap.2010.31.3380","article-title":"Allergic and mixed rhinitis: epidemiology and natural history","volume":"31","author":"Bernstein","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.01.031_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/ACI.0b013e3283630cd8","article-title":"Nonallergic rhinitis: therapeutic options","volume":"13","author":"Bernstein","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib17","first-page":"23","article-title":"Epidemiology of rhinitis: allergic and nonallergic","volume":"19","author":"Settipane","year":"2007","journal-title":"Clin Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1081-1206(10)60480-2","article-title":"Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population","volume":"100","author":"Bernstein","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.anai.2012.06.013","article-title":"Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens","volume":"109","author":"Bernstein","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib20","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/all.12002","article-title":"Prevalence and clinical relevance of local allergic rhinitis","volume":"67","author":"Rondon","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaci.2011.06.012","article-title":"Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis","volume":"128","author":"Rondon","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib22","doi-asserted-by":"crossref","first-page":"AB75","DOI":"10.1016\/j.jaci.2013.12.290","article-title":"Phenotyping non-allergic and local allergic rhinitis","volume":"133","author":"Rondon","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaci.2013.10.034","article-title":"Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis","volume":"133","author":"Rondon","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ACI.0000000000000456","article-title":"Is the evidence of local allergic rhinitis growing?","volume":"18","author":"Rondon","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2007.01.006","article-title":"Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis","volume":"119","author":"Rondon","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1081-1206(10)63546-6","article-title":"Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis","volume":"96","author":"Brandt","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/all.13200","article-title":"Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology","volume":"72","author":"Hellings","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11882-015-0511-7","article-title":"Neural abnormalities in nonallergic rhinitis","volume":"15","author":"Bernstein","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2020.01.031_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.iac.2015.12.005","article-title":"Nonallergic rhinitis: mechanism of action","volume":"36","author":"Baroody","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2020.01.031_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11882-016-0638-1","article-title":"Capsaicin for rhinitis","volume":"16","author":"Fokkens","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.jaip.2020.01.031_bib31","first-page":"CD010591","article-title":"Capsaicin for non-allergic rhinitis","author":"Gevorgyan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.01.031_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.08.026","article-title":"Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis","volume":"133","author":"Van Gerven","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2017.08.012","article-title":"Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update","volume":"119","author":"Dykewicz","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0091-6749(94)90148-1","article-title":"A\u00a0double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis","volume":"94","author":"Ratner","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2222.2004.01877.x","article-title":"Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis","volume":"34","author":"Di Lorenzo","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1067\/mai.2002.124467","article-title":"Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis","volume":"109","author":"Pullerits","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14656566.2015.1020789","article-title":"Advances in pharmacotherapy for the treatment of allergic rhinitis: MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps","volume":"16","author":"Bousquet","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaip.2020.01.031_bib38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/all.13272","article-title":"Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10-year follow-up study","volume":"73","author":"Rondon","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2500\/ajra.2016.30.4391","article-title":"Combination therapy in allergic rhinitis: what works and what does not work","volume":"30","author":"Greiwe","year":"2016","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000375","article-title":"Seasonal allergic rhinitis: a focused systematic review and practice parameter update","volume":"17","author":"Wallace","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mai.2000.106040","article-title":"Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial","volume":"105","author":"Meltzer","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib42","first-page":"CD012597","article-title":"Saline irrigation for allergic rhinitis","volume":"6","author":"Head","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.01.031_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/108854198778557962","article-title":"The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis","volume":"19","author":"Kaiser","year":"1998","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.01.031_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1081-1206(10)61289-6","article-title":"Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies","volume":"94","author":"Kim","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-125-2-199607150-00002","article-title":"Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial","volume":"125","author":"Hayden","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2020.01.031_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2500\/ajra.2013.27.3864","article-title":"Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis","volume":"27","author":"Meltzer","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaci.2011.01.037","article-title":"Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis","volume":"127","author":"Baroody","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.anai.2011.11.013","article-title":"Comparative evaluation of nasal blood flow and airflow in the decongestant response to oxymetazoline","volume":"108","author":"Vaidyanathan","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib49","first-page":"30","article-title":"The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: a randomised controlled trial","volume":"34","author":"Thongngarm","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib50","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib51","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib52","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/all.13201","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaip.2014.01.004","article-title":"AAAAI\/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions","volume":"2","author":"Epstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/all.13350","article-title":"Specific immunotherapy in local allergic rhinitis: a randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy","volume":"73","author":"Rondon","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib55","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.061","article-title":"Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: pooled analyses","volume":"138","author":"Durham","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaip.2016.06.019","article-title":"Sublingual immunotherapy for the polyallergic patient","volume":"5","author":"Pepper","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.01.031_bib59","first-page":"S22","article-title":"International Consensus Statement on Allergy and Rhinology: Rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaci.2018.12.986","article-title":"Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology","volume":"143","author":"Dietz de Loos","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib61","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOO.0000000000000503","article-title":"Endotypes of chronic rhinosinusitis","volume":"27","author":"Yip","year":"2019","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.01.031_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2016.06.063","article-title":"Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois","volume":"139","author":"Tan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib65","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.jaip.2020.01.031_bib66","first-page":"Cd009274","article-title":"Topical steroid for chronic rhinosinusitis without polyps","author":"Snidvongs","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jaip.2020.01.031_bib67","first-page":"CD011996","article-title":"Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jaip.2020.01.031_bib68","first-page":"CD006549","article-title":"Topical steroids for nasal polyps","author":"Kalish","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.01.031_bib69","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.2500\/ajra.2013.27.3950","article-title":"The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis","volume":"27","author":"Fandino","year":"2013","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.jaip.2020.01.031_bib70","first-page":"CD011991","article-title":"Short-course oral steroids alone for chronic rhinosinusitis","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jaip.2020.01.031_bib71","first-page":"CD011992","article-title":"Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.01.031_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1513\/pats.200402-002MS","article-title":"Regulation of inflammatory cell function by corticosteroids","volume":"1","author":"Belvisi","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jaip.2020.01.031_bib73","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/alr.21172","article-title":"Distribution of topical agents to the paranasal sinuses: an evidence-based review with recommendations","volume":"3","author":"Thomas","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib74","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.otc.2016.08.011","article-title":"Topical therapies for refractory chronic rhinosinusitis","volume":"50","author":"Sanan","year":"2017","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.jaip.2020.01.031_bib76","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/alr.22093","article-title":"Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery","volume":"8","author":"Harvey","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jamaoto.2018.0667","article-title":"Effect of budesonide added to large-volume, low-pressure saline sinus irrigation for chronic rhinosinusitis: a randomized clinical trial","volume":"144","author":"Tait","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.01.031_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.10.018","article-title":"Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps","volume":"135","author":"Wang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib79","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/coa.13015","article-title":"Post-operative corticosteroid irrigation for chronic rhinosinusitis after endoscopic sinus surgery: a meta-analysis","volume":"43","author":"Yoon","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2020.01.031_bib80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/alr.21044","article-title":"Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis","volume":"2","author":"Han","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib81","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/lary.26140","article-title":"Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening","volume":"126","author":"Smith","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib82","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/alr.22084","article-title":"A\u00a0phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps","volume":"8","author":"Kern","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.MLG.0000199741.08517.99","article-title":"Breath actuated device improves delivery to target sites beyond the nasal valve","volume":"116","author":"Djupesland","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib84","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/alr.22141","article-title":"EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis","volume":"8","author":"Palmer","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1945892418810281","article-title":"NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps","volume":"33","author":"Sindwani","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaci.2018.10.037","article-title":"New delivery forms of nasal corticosteroids","volume":"143","author":"Fokkens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib88","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2020.01.031_bib89","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.01.031_bib90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhino09.144","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis","volume":"48","author":"Pinto","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.01.031_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib92","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.anai.2019.08.077","article-title":"Omalizumab efficacy and safety in nasal polyposis: results from two parallel, double-blind, placebo-controlled trials [abstract]","volume":"123","author":"Gevaert","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib94","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib95","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cea.12472","article-title":"Pathogenesis of nasal polyposis","volume":"45","author":"Hulse","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib97","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000233182","article-title":"Clinical symptoms, free histamine and IgE in patients with nasal polyposis","volume":"69","author":"Drake-Lee","year":"1982","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0003489417731782","article-title":"Anti-IgE and anti-IL-5 biologic therapy in the treatment of nasal polyposis: a systematic review and meta-analysis","volume":"126","author":"Rivero","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2020.01.031_bib99","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/thx.2010.152835","article-title":"Efficacy of omalizumab in the treatment of nasal polyps","volume":"66","author":"Vennera Mdel","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.01.031_bib100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2013.01.024","article-title":"Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma","volume":"110","author":"Tajiri","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib101","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2500\/ajr.2007.21.3060","article-title":"The role of anti-IgE immunoglobulin therapy in nasal polyposis: a pilot study","volume":"21","author":"Penn","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/ACI.0000000000000251","article-title":"Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs","volume":"16","author":"Varricchi","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib103","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1136\/thorax.55.suppl_2.S79","article-title":"Nasal polyposis, eosinophil dominated inflammation, and allergy","volume":"55","author":"Mygind","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.01.031_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11882-015-0583-4","article-title":"Cytokine patterns and endotypes in acute and chronic rhinosinusitis","volume":"16","author":"Scheckenbach","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2020.01.031_bib105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","article-title":"Diagnosis and management of rhinosinusitis: a practice parameter update","volume":"113","author":"Peters","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.jaip.2020.01.031_bib106","first-page":"CD011994","article-title":"Systemic and topical antibiotics for chronic rhinosinusitis","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.01.031_bib107","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","article-title":"Oral steroids and doxycycline: two different approaches to treat nasal polyps","volume":"125","author":"Van Zele","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/alr.21846","article-title":"Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial","volume":"7","author":"Sabino","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib109","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00005537-200405000-00027","article-title":"Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial","volume":"114","author":"Ragab","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1398-9995.2005.00725.x","article-title":"Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments","volume":"60","author":"Alobid","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib111","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1744666X.2016.1220833","article-title":"Chronic rhinosinusitis: the rationale for current treatments","volume":"13","author":"Ghogomu","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib112","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00183169","article-title":"Functional endoscopic sinus surgery: concept, indications and results of the Messerklinger technique","volume":"247","author":"Stammberger","year":"1990","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.01.031_bib113","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2500\/ajra.2011.25.3672","article-title":"Osteomeatal complex obstruction is not associated with adjacent sinus disease in chronic rhinosinusitis with polyps","volume":"25","author":"Leung","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib114","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/lary.23721","article-title":"Eosinophilic rhinosinusitis is not a disease of ostiomeatal occlusion","volume":"123","author":"Snidvongs","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib115","doi-asserted-by":"crossref","unstructured":"Chandra RK, Kern RC, Cutler JL, Welch KC, Russell PT. REMODEL larger cohort with long-term outcomes and meta-analysis of standalone balloon dilation studies. Laryngoscope 2016;126:44-50.","DOI":"10.1002\/lary.25507"},{"key":"10.1016\/j.jaip.2020.01.031_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/alr.21541","article-title":"Outcomes of complete vs targeted approaches to endoscopic sinus surgery","volume":"5","author":"DeConde","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib117","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/alr.20081","article-title":"Retrospective study of full-house functional endoscopic sinus surgery for revision endoscopic sinus surgery","volume":"1","author":"Shen","year":"2011","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib118","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/alr.21661","article-title":"Subepithelial inflammatory load and basement membrane thickening in refractory chronic rhinosinusitis with nasal polyposis: a histopathological study","volume":"6","author":"Bassiouni","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib119","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/alr.21047","article-title":"Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis","volume":"2","author":"Snidvongs","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lary.23610","article-title":"Role of frontal sinus surgery in nasal polyp recurrence","volume":"123","author":"Bassiouni","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib121","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/alr.21723","article-title":"The endoscopic modified Lothrop procedure: finally ready for prime time in the management of inflammatory sinus disease","volume":"6","author":"Smith","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib122","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/alr.21686","article-title":"Frontal sinus surgery and sinus distribution of nasal irrigation","volume":"6","author":"Barham","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib123","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/lary.27815","article-title":"Endoscopic sinus surgery for type-2 CRS wNP: an endotype-based retrospective study","volume":"129","author":"Alsharif","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib124","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/alr.21739","article-title":"Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis","volume":"6","author":"Morrissey","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOO.0000000000000425","article-title":"The role of frontal sinus drillouts in nasal polyposis","volume":"26","author":"Orgain","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.01.031_bib126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/all.12983","article-title":"Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre","volume":"72","author":"van der Veen","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib127","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/alr.22369","article-title":"Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/alr.21769","article-title":"Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND\/UCLA appropriateness study","volume":"6","author":"Rudmik","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib130","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/lary.27227","article-title":"Appropriateness criteria predict outcomes for sinus surgery and may aid in future patient selection","volume":"128","author":"Beswick","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.01.031_bib131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib132","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/17476348.2018.1417843","article-title":"An update on the management of aspirin-exacerbated respiratory disease","volume":"12","author":"Lee","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2020.01.031_bib134","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","article-title":"Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice","volume":"328","author":"Jenkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2020.01.031_bib135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis: role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.01.031_bib136","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib137","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4168\/aair.2019.11.6.779","article-title":"Complementary participation of genetics and epigenetics in development of NSAID-exacerbated respiratory disease","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.01.031_bib138","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2017.01.022","article-title":"Microparticles in nasal lavage fluids in chronic rhinosinusitis: potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease","volume":"140","author":"Takahashi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib139","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.01.031_bib140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib141","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.031_bib142","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1398-9995.2009.02204.x","article-title":"CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE\/anti-IgE treated nasal polyp tissue","volume":"65","author":"Perez-Novo","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.031_bib143","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.031_bib144","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2020.01.031_bib145","first-page":"165","article-title":"CRTH2 antagonists in asthma: current perspectives","volume":"9","author":"Singh","year":"2017","journal-title":"Clin Pharmacol Adv Appl"},{"key":"10.1016\/j.jaip.2020.01.031_bib146","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00670-2017","article-title":"Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids","volume":"50","author":"Bateman","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.01.031_bib147","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.iac.2016.06.011","article-title":"Mechanisms of benefit with aspirin therapy in aspirin-exacerbated respiratory disease","volume":"36","author":"Hill","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2020.01.031_bib148","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/alr.22418","article-title":"Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients","volume":"9","author":"Shah","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.01.031_bib149","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/alr.22428","article-title":"Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: a systematic review and meta-analysis","volume":"9","author":"Chu","year":"2019","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:21:13Z","timestamp":1761974473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213219820300714"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and Future Treatments of Rhinitis and Sinusitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}